Sarah Cobey to Influenza Vaccines
This is a "connection" page, showing publications Sarah Cobey has written about Influenza Vaccines.
Connection Strength
6.666
-
Reduced Effectiveness of Repeat Influenza Vaccination: Distinguishing Among Within-Season Waning, Recent Clinical Infection, and Subclinical Infection. J Infect Dis. 2024 Dec 16; 230(6):1309-1318.
Score: 0.782
-
Preliminary Findings From the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: A Randomized Controlled Trial. Clin Infect Dis. 2024 10 15; 79(4):901-909.
Score: 0.773
-
The Potential Beneficial Effects of Vaccination on Antigenically Evolving Pathogens. Am Nat. 2022 02; 199(2):223-237.
Score: 0.637
-
Earliest infections predict the age distribution of seasonal influenza A cases. Elife. 2020 07 07; 9.
Score: 0.575
-
Response to Skowronski and De Serres. Clin Infect Dis. 2018 10 15; 67(9):1476.
Score: 0.510
-
Repeated Vaccination May Protect Children From Influenza Infection. JAMA Netw Open. 2018 10 05; 1(6):e183730.
Score: 0.509
-
Estimating Vaccine-Driven Selection in Seasonal Influenza. Viruses. 2018 09 18; 10(9).
Score: 0.507
-
Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013. Clin Infect Dis. 2018 07 18; 67(3):327-333.
Score: 0.501
-
Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutinins. Immunity. 2025 Apr 08; 58(4):980-996.e7.
Score: 0.199
-
Vaccination against rapidly evolving pathogens and the entanglements of memory. Nat Immunol. 2024 Nov; 25(11):2015-2023.
Score: 0.193
-
High-throughput sequencing-based neutralization assay reveals how repeated vaccinations impact titers to recent human H1N1 influenza strains. J Virol. 2024 Oct 22; 98(10):e0068924.
Score: 0.192
-
An Egg-Derived Sulfated N-Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines. mBio. 2021 06 29; 12(3):e0083821.
Score: 0.153
-
Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans. Sci Transl Med. 2020 12 09; 12(573).
Score: 0.148
-
Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein-Based Influenza Vaccines During the 2017-2018 Season. Clin Infect Dis. 2020 09 12; 71(6):1447-1453.
Score: 0.146
-
Age-specific differences in the dynamics of protective immunity to influenza. Nat Commun. 2019 04 10; 10(1):1660.
Score: 0.132
-
Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals. Cell Host Microbe. 2019 03 13; 25(3):357-366.e6.
Score: 0.131
-
Spec-seq unveils transcriptional subpopulations of antibody-secreting cells following influenza vaccination. J Clin Invest. 2019 01 02; 129(1):93-105.
Score: 0.128
-
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc Natl Acad Sci U S A. 2017 11 21; 114(47):12578-12583.
Score: 0.119
-
Immune history and influenza virus susceptibility. Curr Opin Virol. 2017 02; 22:105-111.
Score: 0.113
-
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010. Influenza Other Respir Viruses. 2013 Sep; 7 Suppl 2:52-53.
Score: 0.089
-
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010. Influenza Other Respir Viruses. 2012 Mar; 6(2):142-52, e1-5.
Score: 0.077
-
Immune history shapes human antibody responses to H5N1 influenza viruses. Nat Med. 2025 May; 31(5):1454-1458.
Score: 0.050